Redefining skin with their MicroDot tattoo technology
CipherX is a biotech startup pioneering the design and manufacture of cutting-edge microneedle technology for lifestyle, cosmetic, and medical applications.
Their flagship MicroDot tattoo technology introduces a new way to deliver tattoos that are painless, safer than ever, and enabled by dissolvable biopolymer microneedles. Building on the rich cultural history of tattooing, CipherX envisions skin as a platform for the future where science, design, and engineering unlock new possibilities for expression, health, beauty, and human interaction.
At Material Matters 2025, they will be unveiling their MicroDot tattoo technology, set to launch in early 2026. Their exhibition “The Future of Skin” treats skin as both a biological surface and cultural canvas. CipherX will present a new material language for body art that merges medical precision with artistic expression: simple forms, exposed materiality, and tactility over sterile minimalism and cosmetic sleekness.